Structure

Physi-Chem Properties

Molecular Weight:  618.39
Volume:  666.047
LogP:  7.148
LogD:  5.425
LogS:  -4.638
# Rotatable Bonds:  5
TPSA:  104.06
# H-Bond Aceptor:  6
# H-Bond Donor:  3
# Rings:  6
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.135
Synthetic Accessibility Score:  4.933
Fsp3:  0.692
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.353
MDCK Permeability:  1.5765825082780793e-05
Pgp-inhibitor:  0.048
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.008
20% Bioavailability (F20%):  0.521
30% Bioavailability (F30%):  0.66

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.024
Plasma Protein Binding (PPB):  101.27690124511719%
Volume Distribution (VD):  0.566
Pgp-substrate:  2.320446252822876%

ADMET: Metabolism

CYP1A2-inhibitor:  0.029
CYP1A2-substrate:  0.318
CYP2C19-inhibitor:  0.204
CYP2C19-substrate:  0.567
CYP2C9-inhibitor:  0.111
CYP2C9-substrate:  0.986
CYP2D6-inhibitor:  0.214
CYP2D6-substrate:  0.472
CYP3A4-inhibitor:  0.123
CYP3A4-substrate:  0.228

ADMET: Excretion

Clearance (CL):  1.354
Half-life (T1/2):  0.177

ADMET: Toxicity

hERG Blockers:  0.06
Human Hepatotoxicity (H-HT):  0.415
Drug-inuced Liver Injury (DILI):  0.014
AMES Toxicity:  0.007
Rat Oral Acute Toxicity:  0.04
Maximum Recommended Daily Dose:  0.946
Skin Sensitization:  0.764
Carcinogencity:  0.01
Eye Corrosion:  0.005
Eye Irritation:  0.854
Respiratory Toxicity:  0.603

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC469447

Natural Product ID:  NPC469447
Common Name*:   3Alpha-O-Caffeoylolean-12-En-27-Oic Acid
IUPAC Name:   (4aR,6aR,6aR,6bR,8aR,10R,12aR,14bR)-10-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-2,2,4a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-6a-carboxylic acid
Synonyms:  
Standard InCHIKey:  LWJORTCWCRJUEH-QHCDZFOOSA-N
Standard InCHI:  InChI=1S/C39H54O6/c1-34(2)18-19-36(5)20-21-39(33(43)44)25(26(36)23-34)10-12-30-37(6)16-15-31(35(3,4)29(37)14-17-38(30,39)7)45-32(42)13-9-24-8-11-27(40)28(41)22-24/h8-11,13,22,26,29-31,40-41H,12,14-21,23H2,1-7H3,(H,43,44)/b13-9+/t26-,29-,30+,31+,36+,37-,38+,39+/m0/s1
SMILES:  O=C(O[C@@H]1CC[C@]2([C@H](C1(C)C)CC[C@@]1([C@@H]2CC=C2[C@]1(CC[C@@]1([C@H]2CC(C)(C)CC1)C)C(=O)O)C)C)/C=C/c1ccc(c(c1)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1079030
PubChem CID:   44254694
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO24475 Aceriphyllum rossii n.a. n.a. n.a. n.a. n.a. n.a. PMID[19618898]
NPO24475 Aceriphyllum rossii n.a. n.a. n.a. n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT83 Cell Line MCF7 Homo sapiens IC50 > 150000.0 nM PMID[514039]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 > 150000.0 nM PMID[514039]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC469447 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC477873
0.9854 High Similarity NPC53520
0.964 High Similarity NPC8102
0.964 High Similarity NPC66894
0.9562 High Similarity NPC27518
0.9562 High Similarity NPC304110
0.9559 High Similarity NPC182249
0.9489 High Similarity NPC271494
0.9489 High Similarity NPC473591
0.9489 High Similarity NPC155192
0.9485 High Similarity NPC471152
0.9481 High Similarity NPC477874
0.9481 High Similarity NPC173569
0.9441 High Similarity NPC118033
0.9412 High Similarity NPC249817
0.9375 High Similarity NPC473773
0.9375 High Similarity NPC475579
0.9357 High Similarity NPC25491
0.9343 High Similarity NPC22676
0.9343 High Similarity NPC475482
0.9343 High Similarity NPC198621
0.9343 High Similarity NPC216940
0.9338 High Similarity NPC43353
0.9306 High Similarity NPC473680
0.9306 High Similarity NPC473579
0.9306 High Similarity NPC475454
0.9306 High Similarity NPC475311
0.9281 High Similarity NPC473612
0.9214 High Similarity NPC35212
0.9178 High Similarity NPC205392
0.9178 High Similarity NPC105942
0.9155 High Similarity NPC307205
0.9149 High Similarity NPC235557
0.9149 High Similarity NPC310621
0.9149 High Similarity NPC252133
0.9143 High Similarity NPC172311
0.9137 High Similarity NPC234548
0.9137 High Similarity NPC248287
0.9085 High Similarity NPC26045
0.9051 High Similarity NPC475627
0.9051 High Similarity NPC475346
0.9051 High Similarity NPC475457
0.9051 High Similarity NPC18982
0.9037 High Similarity NPC86257
0.9007 High Similarity NPC472801
0.8913 High Similarity NPC476282
0.8865 High Similarity NPC139243
0.8865 High Similarity NPC116742
0.8844 High Similarity NPC327962
0.8803 High Similarity NPC470617
0.8803 High Similarity NPC471875
0.8803 High Similarity NPC470616
0.8768 High Similarity NPC243305
0.8758 High Similarity NPC266365
0.8741 High Similarity NPC470035
0.8741 High Similarity NPC137416
0.8716 High Similarity NPC145527
0.8716 High Similarity NPC470618
0.8716 High Similarity NPC470619
0.8716 High Similarity NPC208785
0.8714 High Similarity NPC11266
0.8707 High Similarity NPC325032
0.8707 High Similarity NPC477483
0.8652 High Similarity NPC472804
0.863 High Similarity NPC235195
0.863 High Similarity NPC280717
0.863 High Similarity NPC271607
0.863 High Similarity NPC19862
0.8621 High Similarity NPC184935
0.8601 High Similarity NPC132723
0.8601 High Similarity NPC76032
0.8582 High Similarity NPC194970
0.8581 High Similarity NPC32017
0.8581 High Similarity NPC96930
0.8553 High Similarity NPC472807
0.8543 High Similarity NPC475216
0.8543 High Similarity NPC475595
0.8543 High Similarity NPC475145
0.8543 High Similarity NPC266084
0.8543 High Similarity NPC83663
0.8543 High Similarity NPC475162
0.8543 High Similarity NPC473544
0.854 High Similarity NPC190849
0.854 High Similarity NPC171007
0.8535 High Similarity NPC200726
0.8529 High Similarity NPC10154
0.8529 High Similarity NPC265413
0.8523 High Similarity NPC273358
0.8523 High Similarity NPC46549
0.8523 High Similarity NPC264229
0.8523 High Similarity NPC279442
0.8523 High Similarity NPC298647
0.8523 High Similarity NPC292206
0.8521 High Similarity NPC103082
0.8489 Intermediate Similarity NPC30174
0.8481 Intermediate Similarity NPC177362
0.8462 Intermediate Similarity NPC476699
0.8446 Intermediate Similarity NPC470038
0.8446 Intermediate Similarity NPC75295
0.8446 Intermediate Similarity NPC258856
0.8438 Intermediate Similarity NPC469774
0.8438 Intermediate Similarity NPC32723
0.8438 Intermediate Similarity NPC469777
0.8438 Intermediate Similarity NPC469775
0.8438 Intermediate Similarity NPC469778
0.8438 Intermediate Similarity NPC135334
0.8438 Intermediate Similarity NPC469776
0.8438 Intermediate Similarity NPC469772
0.8438 Intermediate Similarity NPC469773
0.8438 Intermediate Similarity NPC100925
0.8438 Intermediate Similarity NPC295941
0.8428 Intermediate Similarity NPC266545
0.8428 Intermediate Similarity NPC202428
0.8389 Intermediate Similarity NPC472937
0.8389 Intermediate Similarity NPC472938
0.8389 Intermediate Similarity NPC472936
0.8387 Intermediate Similarity NPC471750
0.8375 Intermediate Similarity NPC472803
0.8345 Intermediate Similarity NPC471974
0.8345 Intermediate Similarity NPC469680
0.8345 Intermediate Similarity NPC469681
0.8322 Intermediate Similarity NPC471913
0.8313 Intermediate Similarity NPC471870
0.8311 Intermediate Similarity NPC477207
0.8299 Intermediate Similarity NPC472410
0.8289 Intermediate Similarity NPC470037
0.8278 Intermediate Similarity NPC473719
0.8278 Intermediate Similarity NPC477206
0.8276 Intermediate Similarity NPC277559
0.8276 Intermediate Similarity NPC49911
0.8267 Intermediate Similarity NPC474991
0.8267 Intermediate Similarity NPC273798
0.8264 Intermediate Similarity NPC279463
0.8261 Intermediate Similarity NPC474532
0.8248 Intermediate Similarity NPC478058
0.8243 Intermediate Similarity NPC30846
0.8243 Intermediate Similarity NPC471971
0.8243 Intermediate Similarity NPC469855
0.8243 Intermediate Similarity NPC471972
0.8235 Intermediate Similarity NPC470848
0.8235 Intermediate Similarity NPC470849
0.8231 Intermediate Similarity NPC38473
0.8231 Intermediate Similarity NPC29599
0.8227 Intermediate Similarity NPC475138
0.8227 Intermediate Similarity NPC131684
0.8224 Intermediate Similarity NPC472939
0.8207 Intermediate Similarity NPC7464
0.82 Intermediate Similarity NPC84786
0.82 Intermediate Similarity NPC320734
0.8188 Intermediate Similarity NPC471876
0.8188 Intermediate Similarity NPC199936
0.8182 Intermediate Similarity NPC471874
0.8163 Intermediate Similarity NPC106055
0.8163 Intermediate Similarity NPC110699
0.816 Intermediate Similarity NPC471871
0.8158 Intermediate Similarity NPC132810
0.8148 Intermediate Similarity NPC203124
0.8148 Intermediate Similarity NPC309434
0.8146 Intermediate Similarity NPC246229
0.8146 Intermediate Similarity NPC471970
0.8146 Intermediate Similarity NPC191899
0.8143 Intermediate Similarity NPC470753
0.8143 Intermediate Similarity NPC473220
0.8141 Intermediate Similarity NPC471968
0.8133 Intermediate Similarity NPC145301
0.8133 Intermediate Similarity NPC144247
0.8133 Intermediate Similarity NPC469856
0.8133 Intermediate Similarity NPC469375
0.8133 Intermediate Similarity NPC469854
0.8133 Intermediate Similarity NPC294679
0.8133 Intermediate Similarity NPC8493
0.8129 Intermediate Similarity NPC288945
0.8129 Intermediate Similarity NPC62051
0.8125 Intermediate Similarity NPC475468
0.8125 Intermediate Similarity NPC168799
0.8125 Intermediate Similarity NPC155209
0.8117 Intermediate Similarity NPC124842
0.8113 Intermediate Similarity NPC471873
0.8112 Intermediate Similarity NPC198388
0.8108 Intermediate Similarity NPC82336
0.8108 Intermediate Similarity NPC78987
0.8105 Intermediate Similarity NPC142654
0.8099 Intermediate Similarity NPC470747
0.8095 Intermediate Similarity NPC42384
0.8095 Intermediate Similarity NPC5014
0.8095 Intermediate Similarity NPC289358
0.8095 Intermediate Similarity NPC50615
0.8095 Intermediate Similarity NPC469857
0.8095 Intermediate Similarity NPC477849
0.8095 Intermediate Similarity NPC51531
0.8095 Intermediate Similarity NPC91887
0.8095 Intermediate Similarity NPC28592
0.8095 Intermediate Similarity NPC245760
0.8095 Intermediate Similarity NPC23667
0.8095 Intermediate Similarity NPC473479
0.8095 Intermediate Similarity NPC165191
0.8095 Intermediate Similarity NPC149773
0.8095 Intermediate Similarity NPC46242
0.8095 Intermediate Similarity NPC297797
0.8095 Intermediate Similarity NPC114333

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC469447 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9779 High Similarity NPD8166 Discontinued
0.8112 Intermediate Similarity NPD6663 Approved
0.8085 Intermediate Similarity NPD5736 Approved
0.805 Intermediate Similarity NPD8127 Discontinued
0.7933 Intermediate Similarity NPD7003 Approved
0.7871 Intermediate Similarity NPD7458 Discontinued
0.7792 Intermediate Similarity NPD6273 Approved
0.7719 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD6190 Approved
0.7643 Intermediate Similarity NPD3019 Approved
0.7643 Intermediate Similarity NPD2932 Approved
0.7616 Intermediate Similarity NPD7266 Discontinued
0.7582 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7582 Intermediate Similarity NPD4110 Phase 3
0.7544 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD8032 Phase 2
0.75 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD6234 Discontinued
0.7485 Intermediate Similarity NPD7228 Approved
0.7468 Intermediate Similarity NPD4628 Phase 3
0.7468 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.745 Intermediate Similarity NPD3620 Phase 2
0.745 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.74 Intermediate Similarity NPD6355 Discontinued
0.7375 Intermediate Similarity NPD7028 Phase 2
0.7365 Intermediate Similarity NPD7095 Approved
0.7362 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7353 Intermediate Similarity NPD3021 Approved
0.7353 Intermediate Similarity NPD3022 Approved
0.7333 Intermediate Similarity NPD4060 Phase 1
0.7333 Intermediate Similarity NPD4140 Approved
0.732 Intermediate Similarity NPD5408 Approved
0.732 Intermediate Similarity NPD5404 Approved
0.732 Intermediate Similarity NPD5405 Approved
0.732 Intermediate Similarity NPD5406 Approved
0.7315 Intermediate Similarity NPD3764 Approved
0.7315 Intermediate Similarity NPD6798 Discontinued
0.7312 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7312 Intermediate Similarity NPD3455 Phase 2
0.731 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7303 Intermediate Similarity NPD7097 Phase 1
0.7292 Intermediate Similarity NPD3092 Approved
0.7285 Intermediate Similarity NPD230 Phase 1
0.7284 Intermediate Similarity NPD37 Approved
0.7278 Intermediate Similarity NPD4160 Clinical (unspecified phase)
0.7261 Intermediate Similarity NPD7236 Approved
0.726 Intermediate Similarity NPD1283 Approved
0.7256 Intermediate Similarity NPD4966 Approved
0.7256 Intermediate Similarity NPD4967 Phase 2
0.7256 Intermediate Similarity NPD4965 Approved
0.7254 Intermediate Similarity NPD3091 Approved
0.7248 Intermediate Similarity NPD7008 Discontinued
0.7248 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7235 Intermediate Similarity NPD5844 Phase 1
0.7225 Intermediate Similarity NPD8313 Approved
0.7225 Intermediate Similarity NPD8312 Approved
0.7222 Intermediate Similarity NPD3026 Approved
0.7222 Intermediate Similarity NPD3023 Approved
0.7219 Intermediate Similarity NPD826 Approved
0.7219 Intermediate Similarity NPD825 Approved
0.7215 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7214 Intermediate Similarity NPD2629 Approved
0.7211 Intermediate Similarity NPD3094 Phase 2
0.7208 Intermediate Similarity NPD2935 Discontinued
0.7203 Intermediate Similarity NPD3025 Approved
0.7203 Intermediate Similarity NPD3024 Approved
0.72 Intermediate Similarity NPD8150 Discontinued
0.717 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7153 Intermediate Similarity NPD4626 Approved
0.7152 Intermediate Similarity NPD7768 Phase 2
0.7151 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7118 Intermediate Similarity NPD7473 Discontinued
0.7105 Intermediate Similarity NPD2979 Phase 3
0.7097 Intermediate Similarity NPD2438 Suspended
0.7095 Intermediate Similarity NPD2797 Approved
0.7089 Intermediate Similarity NPD7910 Clinical (unspecified phase)
0.7083 Intermediate Similarity NPD5691 Approved
0.707 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD5735 Approved
0.7055 Intermediate Similarity NPD1281 Approved
0.7042 Intermediate Similarity NPD4198 Discontinued
0.7041 Intermediate Similarity NPD6232 Discontinued
0.7039 Intermediate Similarity NPD6233 Phase 2
0.7037 Intermediate Similarity NPD7239 Suspended
0.7034 Intermediate Similarity NPD3095 Discontinued
0.7032 Intermediate Similarity NPD3299 Clinical (unspecified phase)
0.7032 Intermediate Similarity NPD2799 Discontinued
0.703 Intermediate Similarity NPD8455 Phase 2
0.703 Intermediate Similarity NPD7819 Suspended
0.7029 Intermediate Similarity NPD3534 Clinical (unspecified phase)
0.7025 Intermediate Similarity NPD3750 Approved
0.7014 Intermediate Similarity NPD9545 Approved
0.7012 Intermediate Similarity NPD6677 Suspended
0.7011 Intermediate Similarity NPD7685 Pre-registration
0.7011 Intermediate Similarity NPD7240 Approved
0.7 Intermediate Similarity NPD9494 Approved
0.6988 Remote Similarity NPD8438 Clinical (unspecified phase)
0.698 Remote Similarity NPD1470 Approved
0.6974 Remote Similarity NPD3268 Approved
0.6972 Remote Similarity NPD5951 Approved
0.697 Remote Similarity NPD1934 Approved
0.6959 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6959 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6959 Remote Similarity NPD6166 Phase 2
0.6959 Remote Similarity NPD5327 Phase 3
0.6957 Remote Similarity NPD7446 Clinical (unspecified phase)
0.695 Remote Similarity NPD6858 Approved
0.695 Remote Similarity NPD7094 Approved
0.6948 Remote Similarity NPD555 Phase 2
0.6944 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6943 Remote Similarity NPD5762 Approved
0.6943 Remote Similarity NPD5763 Approved
0.6943 Remote Similarity NPD2346 Discontinued
0.6939 Remote Similarity NPD1201 Approved
0.6933 Remote Similarity NPD257 Approved
0.6933 Remote Similarity NPD258 Approved
0.6918 Remote Similarity NPD7163 Clinical (unspecified phase)
0.691 Remote Similarity NPD8434 Phase 2
0.6909 Remote Similarity NPD6873 Phase 2
0.6906 Remote Similarity NPD6831 Clinical (unspecified phase)
0.6905 Remote Similarity NPD7075 Discontinued
0.6901 Remote Similarity NPD4869 Clinical (unspecified phase)
0.6899 Remote Similarity NPD4534 Discontinued
0.6897 Remote Similarity NPD7074 Phase 3
0.6894 Remote Similarity NPD7390 Discontinued
0.6886 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6883 Remote Similarity NPD943 Approved
0.6882 Remote Similarity NPD7199 Phase 2
0.6879 Remote Similarity NPD6100 Approved
0.6879 Remote Similarity NPD6099 Approved
0.6879 Remote Similarity NPD2531 Phase 2
0.686 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6855 Remote Similarity NPD6674 Discontinued
0.6849 Remote Similarity NPD1651 Approved
0.6849 Remote Similarity NPD5585 Approved
0.6839 Remote Similarity NPD7054 Approved
0.6832 Remote Similarity NPD3300 Phase 2
0.6828 Remote Similarity NPD5536 Phase 2
0.6826 Remote Similarity NPD1465 Phase 2
0.6826 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6818 Remote Similarity NPD4062 Phase 3
0.6818 Remote Similarity NPD259 Phase 1
0.6818 Remote Similarity NPD7961 Discontinued
0.6803 Remote Similarity NPD1778 Approved
0.6803 Remote Similarity NPD4059 Approved
0.6802 Remote Similarity NPD7184 Clinical (unspecified phase)
0.68 Remote Similarity NPD7472 Approved
0.6798 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6797 Remote Similarity NPD3027 Phase 3
0.6795 Remote Similarity NPD6353 Approved
0.6795 Remote Similarity NPD6653 Approved
0.6792 Remote Similarity NPD970 Clinical (unspecified phase)
0.6788 Remote Similarity NPD3226 Approved
0.6784 Remote Similarity NPD6959 Discontinued
0.6783 Remote Similarity NPD5283 Phase 1
0.6779 Remote Similarity NPD3972 Approved
0.6779 Remote Similarity NPD9269 Phase 2
0.6779 Remote Similarity NPD1608 Approved
0.6772 Remote Similarity NPD4477 Approved
0.6772 Remote Similarity NPD4476 Approved
0.6761 Remote Similarity NPD228 Approved
0.6759 Remote Similarity NPD9493 Approved
0.6757 Remote Similarity NPD3496 Discontinued
0.6755 Remote Similarity NPD7680 Approved
0.6755 Remote Similarity NPD1164 Approved
0.6753 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6747 Remote Similarity NPD4380 Phase 2
0.6747 Remote Similarity NPD6599 Discontinued
0.6746 Remote Similarity NPD3882 Suspended
0.6739 Remote Similarity NPD5909 Discontinued
0.6735 Remote Similarity NPD4196 Clinical (unspecified phase)
0.6733 Remote Similarity NPD3600 Clinical (unspecified phase)
0.6731 Remote Similarity NPD3657 Discovery
0.6731 Remote Similarity NPD447 Suspended
0.673 Remote Similarity NPD7702 Clinical (unspecified phase)
0.673 Remote Similarity NPD2029 Clinical (unspecified phase)
0.6726 Remote Similarity NPD2801 Approved
0.6723 Remote Similarity NPD7251 Discontinued
0.672 Remote Similarity NPD7237 Clinical (unspecified phase)
0.6711 Remote Similarity NPD4624 Approved
0.6711 Remote Similarity NPD2798 Approved
0.6709 Remote Similarity NPD1509 Clinical (unspecified phase)
0.6709 Remote Similarity NPD4308 Phase 3
0.6709 Remote Similarity NPD3748 Approved
0.6707 Remote Similarity NPD7411 Suspended
0.6706 Remote Similarity NPD7832 Clinical (unspecified phase)
0.6706 Remote Similarity NPD7833 Phase 2
0.6706 Remote Similarity NPD7831 Phase 2
0.6705 Remote Similarity NPD8051 Clinical (unspecified phase)
0.6703 Remote Similarity NPD2490 Approved
0.6703 Remote Similarity NPD2488 Approved
0.6691 Remote Similarity NPD3020 Approved
0.669 Remote Similarity NPD7157 Approved
0.6689 Remote Similarity NPD8651 Approved
0.6689 Remote Similarity NPD3412 Clinical (unspecified phase)
0.6687 Remote Similarity NPD5958 Discontinued
0.6687 Remote Similarity NPD1511 Approved
0.6686 Remote Similarity NPD3817 Phase 2
0.6686 Remote Similarity NPD3818 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data